Length of stay after an enhanced recovery pathway in patients after cardiac surgery: A quality-improvement audit
Published
July 26, 2025
Paper ID
PAP-000037
Status
Published
DOI
10.65712/tmj.test000295
Advance Services
Abstract
Background: length of stay remains a leading cause of avoidable harm among patients after cardiac surgery. Methods: We conducted a quality-improvement audit across 8 centres between 2015 and 2024. Results: 2625 participants were included (median age 28 years). Effects were consistent across prespecified subgroups. Conclusion: These findings suggest that an enhanced recovery pathway is associated with better length of stay in patients after cardiac surgery.
Introduction
Practice around an enhanced recovery pathway varies widely between centres. length of stay remains a leading cause of avoidable harm among patients after cardiac surgery.
Practice around an enhanced recovery pathway varies widely between centres. Earlier studies of an enhanced recovery pathway were small or single-centre. The cost of length of stay to health systems is substantial.
Practice around an enhanced recovery pathway varies widely between centres.
Materials and Methods
Eligible participants were patients after cardiac surgery. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were patients after cardiac surgery.
Results
Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Centre A | 370 | 60 | 29.1 | 0.99 | 0.30–1.12 |
| Centre B | 895 | 95 | 13.9 | 0.93 | 0.46–1.39 |
| Male | 256 | 21 | 8.1 | 0.95 | 0.49–1.39 |
| Female | 353 | 81 | 3.9 | 0.99 | 0.28–1.29 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.68 (95% CI 0.29 to 0.61).
Discussion
Residual confounding cannot be excluded. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols. Future work should test an enhanced recovery pathway in a pragmatic multicentre trial.
Conclusions
An enhanced recovery pathway should be considered for patients after cardiac surgery to improve length of stay.
References
1. Dubois D, Rahman S, et al. Nurse-led discharge planning and health-related quality of life. BMC Med. 2021;19(6):601-1737.
2. Ibrahim C, Mueller R, et al. Home-based cardiac rehabilitation and surgical site infection. Lancet. 2022;298(9):161-1676.
3. Farouk U, Rahman T, et al. An antibiotic stewardship programme and glycaemic control. Pediatrics. 2012;76(6):309-951.
4. Nasser A, Osei O, et al. A sepsis alert system and medication adherence. N Engl J Med. 2010;321(8):573-1594.
5. Novak G, Mensah M, et al. Home-based cardiac rehabilitation and falls. BMJ. 2010;250(3):738-981.
6. Silva I, Tanaka Q, et al. Point-of-care ultrasound and acute kidney injury. JAMA. 2014;363(6):585-1765.
Appendices
Supplementary tables are available on request.